RALTEGRAVIR POTASSIUM, TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Defense Logistics Agency award SPE2D226F3284 is a firm-fixed-price delivery order issued under the primary contract SPE2DX25D9822 to DMS Pharmaceutical Group Inc, a women-owned small business. The contract, signed on March 7, 2025, is for the procurement of two bottles of Raltegravir Potassium tablets (NSN 6505016218317) for a total price of $2,930.36. The items are to be delivered to the USS Barry DDG 52 by August 17, 2026. The acquisition is governed by FAR Part 12 for commercial items, with the award based on the lowest quoted price. Terms are set as FOB Destination, with the contractor bearing all transportation costs and risks until delivery. Inspection and acceptance are conducted by the government at the destination. Administrative oversight is managed by the DLA Troop Support Medical Supply Chain, with payment processed through the Defense Finance and Accounting Service in Columbus, Ohio. The order is designated as a rated order under the Defense Priorities and Allocation System.
General Info
Agency
Contract Value
$2,930.36NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
